Apria announces launch of 7.5 million shares
By HME News Staff
Updated 12:32 PM CST, Thu February 4, 2021
INDIANAPOLIS – Apria Healthcare has announced the launch of its initial public offering of 7.5 million shares of its common stock, with an initial offering price expected to be between $19 - $21 per share.
The selling stockholders expect to grant the underwriters a 30-day option to purchase up to an additional 1.125 million shares of common stock.
Apria will not receive any net proceeds from the sale of its common stock by the selling stockholders, including from any exercise by the underwriters of their option to purchase additional shares of the common stock from the selling stockholders.
Citigroup and Goldman Sachs & Co. LLC are acting as joint lead book-running managers for the offering. BofA Securities, J.P. Morgan and UBS Investment Bank are acting as joint book-running managers for the offering. Piper Sandler, Citizens Capital Markets, Fifth Third Securities and TD Securities are acting as co-managers for the offering.
Apria intends to list its shares of common stock on the Nasdaq Global Select Market under the symbol “APR.” Apria on Jan. 15 filed a Form S-1 with the Securities and Exchange Commission, a step it must take before filing an initial public offering.
Comments